Latest news
Marvel Biosciences’ MB-204 Shows Robust Efficacy in Fragile X Preclinical Study - TipRanksTipRanks · Wed, 05 Aug 2026 10:36:48 GMTMarvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X - The Manila TimesThe Manila Times · Wed, 05 Aug 2026 09:14:37 GMT